دورية أكاديمية

Optimal ICSI timing on immature oocytes for low prognosis patients under the POSEIDON classification.

التفاصيل البيبلوغرافية
العنوان: Optimal ICSI timing on immature oocytes for low prognosis patients under the POSEIDON classification.
المؤلفون: Shi C; Reproductive Medical Center, Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China., Wang P; Reproductive Medical Center, Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China., Liang R; Reproductive Medical Center, Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China., Fu M; Reproductive Medical Center, Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China., Duan SN; Reproductive Medical Center, Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China., Shen H; Reproductive Medical Center, Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China., Yang M; Beijing Qiaozhao Xinye Biology Science and Technology Company Co., Ltd, Beijing, China. ymdoctor@163.com., Chen X; Reproductive Medical Center, Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China. chenxi@pkuph.edu.cn.
المصدر: BMC pregnancy and childbirth [BMC Pregnancy Childbirth] 2024 Jun 06; Vol. 24 (1), pp. 407. Date of Electronic Publication: 2024 Jun 06.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967799 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2393 (Electronic) Linking ISSN: 14712393 NLM ISO Abbreviation: BMC Pregnancy Childbirth Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: Sperm Injections, Intracytoplasmic*/methods , Oocytes* , Embryonic Development* , In Vitro Oocyte Maturation Techniques*/methods, Humans ; Female ; Pregnancy ; Adult ; Time Factors ; Prospective Studies ; Prognosis ; Pregnancy Rate ; Oocyte Retrieval/methods ; Embryo Transfer/methods ; Blastocyst ; Embryo Culture Techniques/methods ; Polar Bodies
مستخلص: Background: The optimal timing of performing ICSI on immature oocytes for POSEIDON patients is still unknown to get better early embryonic development outcomes. The purpose of this study was to implore the most appropriate time to carry out ICSI on in vitro maturation GV and MI oocytes for POSEIDON patients.
Methods: Two hundred thirty-nine immature oocytes from 163 POSEIDON patients were prospectively performed ICSI at different timings: P-ICSI (ICSI was performed on in vitro matured oocytes 4-6 h after the first polar body extrusion, N = 81), R-ICSI (ICSI was performed on in vitro matured oocytes less than 4 h after the first polar body extrusion, N = 80), and E-ICSI (ICSI was performed on in vitro matured oocytes the next day after oocytes retrieval, N = 78). Fertilization and embryonic development outcomes were collected and statistically analyzed. Mitochondria distribution of cytoplasm of in vitro matured oocytes with different time cultures after the first polar body (PB1) extrusion was stained.
Results: Compared to the E-ICSI group, more day 3 embryos from P-ICSI became blastocysts after sequential culture though without statistical significance (OR = 3.71, 95% CI: 0.94-14.63, P = 0.061). Compared to the E-ICSI group, more embryos from both P-ICSI and R-ICSI groups were clinically used with statistical significance (OR = 5.67, 95% CI: 2.24-14.35, P = 0.000 for P-ICSI embryos; OR = 3.23, 95% CI: 1.23-8.45, P = 0.017 for R-ICSI embryos). Compared to the E-ICSI group, transferred embryos from P-ICSI and R-ICSI had a higher implantation rate though without statistical significance (35.3% for P-ICSI embryos; 9.1% or R-ICSI embryos and 0% for E-ICSI embryos, P = 0.050). Among the three group, there were most healthy babies delivered from the P-ICSI group (5, 1 and 0 for P-ICSI, R-ICSI and E-ICSI respectively). The mitochondria in the cytoplasm of in vitro matured oocytes with a less than 4 h and 4-6 h culture after PB1 extrusion presented semiperipheral and diffused distribution patterns, respectively.
Conclusions: Our results revealed P-ICSI (ICSI was performed on in vitro matured oocytes 4-6 h after the first polar body extrusion) provided the most efficient method to utilize the immaturation oocytes basing on embryos utilization and live birth outcome for low prognosis patients under the POSEIDON classification. The mitochondria distribution of the in vitro matured oocytes' cytoplasm from P-ICSI varied that from R-ICSI.
(© 2024. The Author(s).)
References: Hum Reprod. 2007 Jul;22(7):1991-5. (PMID: 17513319)
Hum Reprod. 2000 Dec;15(12):2634-43. (PMID: 11098037)
Reprod Biol Endocrinol. 2021 Mar 1;19(1):34. (PMID: 33648503)
Fertil Steril. 2016 Jun;105(6):1452-3. (PMID: 26921622)
Fertil Steril. 1991 Jan;55(1):109-13. (PMID: 1986950)
Hum Reprod. 2021 Jul 19;36(8):2157-2169. (PMID: 34179973)
Indian J Med Res. 2013 Feb;137(2):331-8. (PMID: 23563377)
Fertil Steril. 2010 Mar 15;93(5):1550-5. (PMID: 19423101)
Endocrine. 2016 Apr;52(1):165-71. (PMID: 26419849)
Hum Fertil (Camb). 2022 Feb;25(1):107-116. (PMID: 31948310)
Anim Reprod Sci. 2007 Mar;98(1-2):72-96. (PMID: 17110061)
Int J Endocrinol. 2022 Mar 12;2022:6368678. (PMID: 35313456)
Reprod Biomed Online. 2019 Nov;39(5):751-763. (PMID: 31540848)
Curr Womens Health Rep. 2001 Oct;1(2):143-51. (PMID: 12112961)
Hum Reprod. 2019 Jun 4;34(6):1030-1041. (PMID: 31125412)
Hum Reprod. 1999 Sep;14 Suppl 1:145-61. (PMID: 10573031)
Dev Genet. 1995;16(1):36-43. (PMID: 7538924)
J Hum Reprod Sci. 2021 Oct-Dec;14(4):415-421. (PMID: 35197688)
Fertil Steril. 2011 Jul;96(1):73-78.e1. (PMID: 21645890)
Hum Reprod. 2020 Oct 1;35(10):2226-2236. (PMID: 32951048)
Hum Reprod. 1995 Feb;10(2):415-24. (PMID: 7769073)
فهرسة مساهمة: Keywords: GEE; ICSI timing; Immature oocytes; Mitochondria distribution; POSEIDON patients
تواريخ الأحداث: Date Created: 20240606 Date Completed: 20240606 Latest Revision: 20240609
رمز التحديث: 20240609
مُعرف محوري في PubMed: PMC11155078
DOI: 10.1186/s12884-024-06577-x
PMID: 38844840
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-2393
DOI:10.1186/s12884-024-06577-x